Thermo Fisher Scientific Bioproduction Articles

1. Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy 2/6/2026

   The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

2. Integrated Upstream And Downstream Strategies For Robust mAb Manufacturing 2/5/2026

   Process robust mAb production requires understanding scale dependent cell environments, leveraging predictive models, and pursuing data driven control to minimize variability, optimize quality, and ensure reliable technology transfer across biomanufacturing scales.

3. Rethinking Peptones As First-Line Optimization Tools 11/14/2025

   Peptones enhance CHO cell growth, viability, and yield, offering a fast, low-risk way to improve bioprocess performance without major process changes.

4. How Can You Avoid Bioprocessing Risks When Using Cable Ties? 10/15/2025

   Cable ties in bioprocessing can cause leaks, damage, and delays. See how switching to a uniform-sealing connector can significantly improve efficiency, reduce prep time, and minimize contamination risks.

5. Simplify Process Scale-Up With An Innovative Single-Use Bioreactor 10/15/2025

   Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.

6. Advanced Aseptic Filling Assembly Helium Integrity Testing 10/15/2025

   Helium leak testing offers unmatched sensitivity for detecting micro-leaks in single-use fill-finish systems. Learn how tighter leak thresholds can strengthen aseptic processing and regulatory confidence.

7. Product Recovery Study For Fill Finish Applications 10/15/2025

   Surge bags are essential to fill finish efficiency, but poor drainage can cause costly product loss. Learn how drainage testing helps identify high-performance bags that maximize recovery and reduce waste.

8. Molecular Approaches To Streamline Cell Therapy Product Analytical Testing 9/26/2025

   Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.

9. Advances In Analytical Method Selection And Technology Transfer 9/26/2025

   Successful analytical method transfer is crucial for product quality and regulatory compliance. Learn best practices for tech transfer, including how gap assessments mitigate common risks and streamline bioprocessing.

10. Streamlining Data For Efficient Therapeutic Manufacturing 9/26/2025

    An integrated solution for impurity and sterility analysis streamlines data, supports regulatory compliance, and uses built-in algorithms to deliver accurate, actionable results quickly.